The fact that “return on investment” needs to be a consideration at all when developing pharmaceuticals is the more fundamental problem.
-
RE: https://med-mastodon.com/@jeneralist/116063720006024901
The fact that “return on investment” needs to be a consideration at all when developing pharmaceuticals is the more fundamental problem.
-
RE: https://med-mastodon.com/@jeneralist/116063720006024901
The fact that “return on investment” needs to be a consideration at all when developing pharmaceuticals is the more fundamental problem.
@drahardja oh my god this is depressing. So much promising medicine shelved because of these ignorant fools.
-
RE: https://med-mastodon.com/@jeneralist/116063720006024901
The fact that “return on investment” needs to be a consideration at all when developing pharmaceuticals is the more fundamental problem.
@drahardja A healthy population is quite the return on investment.
Why the federal government doesn't just make any qualified researchers who wants to research medications and vaccines able to have a subsidized job at a university I'll never know.
-
@drahardja A healthy population is quite the return on investment.
Why the federal government doesn't just make any qualified researchers who wants to research medications and vaccines able to have a subsidized job at a university I'll never know.
@virtuous_sloth NIH grants were one way to do this to some extent (no more, thanks to Trump), but for-profit pharmaceutical companies have a stranglehold in the US.
-
J jwcph@helvede.net shared this topic
